APG Asset Management
IONS icon

APG Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

APG Asset Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-28,200
Closed -$949K – 915
2021
Q2 		$949K Buy
+28,200
New +$1.1M ﹤0.01% 797
2020
Q2 		– Sell
-183,160
Closed -$8.66M – 981
2020
Q1 		$8.66M Sell
183,160
-44,841
-20% -$2.5M 0.02% 582
2019
Q4 		$12.3M Sell
228,001
-441,686
-66% -$26.3M 0.02% 526
2019
Q3 		$36.8M Buy
669,687
+476,087
+246% +$31M 0.06% 318
2019
Q2 		$10.9M Buy
+193,600
New +$13.7M 0.02% 516
2017
Q3 		– Sell
-62,464
Closed -$3.18M – 818
2017
Q2 		$3.18M Hold
62,464
– – 0.01% 621
2017
Q1 		$2.51M Hold
62,464
– – ﹤0.01% 639
2016
Q4 		$2.83M Sell
62,464
-12,400
-17% -$491K 0.01% 655
2016
Q3 		$2.74M Sell
74,864
-68,700
-48% -$2.15M ﹤0.01% 696
2016
Q2 		$3.34M Buy
143,564
+68,700
+92% +$2.22M 0.01% 696
2016
Q1 		$3.03M Buy
74,864
+35,053
+88% +$1.42M 0.01% 665
2015
Q4 		$2.47M Hold
39,811
– – 0.01% 669
2015
Q3 		$1.61M Buy
39,811
+13,150
+49% +$681K ﹤0.01% 698
2015
Q2 		$1.53M Buy
+26,661
New +$1.7M ﹤0.01% 719

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

APG Asset Management's IONS Position: Q3 2021 in Review

APG Asset Management sold out of Ionis Pharmaceuticals (IONS) in Q3 2021, closing a stake of 28,200 shares — an estimated $949K sold.

APG Asset Management first reported a position in IONS in Q2 2015 and held it in 14 quarters. The position peaked at $36.8M in Q3 2019. 324 funds tracked by Wall St. Rank hold IONS as of Q3 2021.

  • APG Asset Management reported no remaining Ionis Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • APG Asset Management sold 28,200 Ionis Pharmaceuticals shares in Q3 2021, an estimated $949K.
  • APG Asset Management first reported a position in Ionis Pharmaceuticals in Q2 2015 and held it in 14 quarters.
  • APG Asset Management's Ionis Pharmaceuticals position peaked at $36.8M in Q3 2019.
  • 324 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2021.

Based on APG Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.